Global /United States /Healthcare /Medical Devices /BDX
chevron_leftBack
Becton, Dickinson and Co. logo

Becton, Dickinson and Co.

BDX
NYSE: BDX Delayed
145.31USD -2.8%
As of 8 July 2026, Becton, Dickinson and Co. has a market cap of $41.38B USD, ranking #597 globally and #262 in the United States. It ranks #53 in the Healthcare sector, and #14 in the Medical Devices industry.
Global Rank
597
1d: -1
1w: +4
1m: -
Country Rank
262
1d: 0
1w: +6
1m: -
Sector Rank
53
1d: 0
1w: 0
1m: -
Industry Rank
14
1d: 0
1w: 0
1m: -
Key Stats
Market Cap
$41.38BUSD
Enterprise Value
$60.09BUSD
Revenue (TTM)
$21.92BUSD
EBITDA (TTM)
$6.04BUSD
Net Income (TTM)
$1.76BUSD
EBITDA Margin
28%
Profit Margin
8%
PE Ratio
24.4
Forward PE
11.6
PS Ratio
1.9
PB Ratio
1.7
EV/EBITDA
9.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Thomas Polen open_in_new
Employees
72,000
Founded
1897
IPO
23 Apr 1962
Website
bd.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.8% -6.6% -6% -28% -21% -29%

News

Loading...

BDX Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
BDX
Becton Dickinson & Co
ISIN: US0758871091
Shares Out.:
275.54M1 Shares Float: 274.959M2
TV:
SA:
YF:
BDX
GF:
NQ:
BDX
BA:
BDX
MS:
145.31 USD
London Stock Exchange
MIC: XLON
0R19
Becton Dickinson & Co
ISIN: US0758871091
TV:
SA:
YF:
GF:
BA:
MS:
145.89 USD
Borsa Italiana
MIC: XMIL
1BDX
Becton Dickinson & Co
ISIN: US0758871091
TV:
SA:
YF:
GF:
BA:
MS:
129.15 EUR
Show all 9 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Becton, Dickinson and Co.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
319%
25.8
$160.73B
288%
56.7
$159.07B
284%
25.6
DHR
$126.55B
206%
34.7
SYK
$120.69B
192%
38.3
$84.93B
105%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
146%
22.2
$96.29B
84.32B EUR
133%
36.7
7741
$60.71B
9.83T JPY
47%
40.0
$44.92B
39.34B EUR
8.6%
18.7
ALC
$35.9B
28.99B CHF
-13%
37.9
$29.97B
203.66B CNY
-28%
26.0
chevron_leftBack